HHS awards $260M to build and renovate health centers

The U.S. Department of Health and Human Services (HHS) has announced 290 health centers around the U.S. will receive more than $260 million in funding to build new facilities or expand existing structures.

The money comes from the Community Health Center Fund, first established by the Affordable Care Act and extended by the passing of the 2015 Medicare Access and CHIP Reauthorization Act (MACRA). The total amount of the awarded funding represents a significant increase from the $150 million for facility renovation and construction announced in September 2015 and the $101 million handed out in May 2015.

“Health centers are cornerstones of the communities they serve,” said HHS Secretary Sylvia Burwell in a statement. “Today’s awards will empower health centers to build more capacity and provide needed healthcare to hundreds of thousands of additional individuals and their families.”

Funding construction and expansion is intended to help health centers keep up with the demand for more physical space at health facilities as more people become insured. HHS said these awards will allow centers to provide care for 800,000 additional patients.

The money will be distributed to facilities in 45 states, along with the District of Columbia and Puerto Rico, with no single center receiving more than $1 million. California is receiving both the most individual awards and the greatest amount of overall funding, with 40 facilities getting more than $36.8 milllion.

No facilities in Delaware, Nevada, New Hampshire, South Dakota or Wyoming are included on the awards list.

A state-by-state listing is available on the HHS site

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.